Eurofins provides risk-based monitoring, medical oversight, pharmacovigilance and centralised monitoring solutions to ensure patient safety, inspection readiness and reliable clinical data across Phase I-IV and medical device studies.

Monitoring of clinical data

businessman-in-formal-shirt-marking-completed-checklist-items-with-white-marker-symbolizing-organization-productivity-and-task-management-success-concepts_6264-x-8316px-1 (1)

Delivering High-Quality Monitoring Across the Clinical Trial Lifecycle

High-quality clinical monitoring is essential to ensure patient safety, data integrity and regulatory compliance. Our experienced Clinical Research Associates (CRAs), supported by clinical and operational experts, deliver tailored risk-based monitoring solutions from study start-up through study close-out.

We support Sponsors through:

  • Risk-based monitoring strategies and monitoring plans
  • Site initiation, monitoring and close-out visits
  • Site training and ongoing support
  • Source data review and verification, as appropriate
  • Oversight of patient safety, eligibility and protocol compliance
  • Centralised and remote monitoring activities
  • Identification and management of protocol deviations and study risks
  • TMF review and inspection readiness support
  • Close collaboration with medical monitoring, pharmacovigilance and data management teams

Through a proactive and patient-centric approach, we help Sponsors safeguard data quality, accelerate decision-making and ensure successful trial execution.

Compliance, Compliance and More Compliance to Mitigate Risk

We are highly conscious of the importance of demonstrating your commitment to patient safety to regulatory authorities. In order to demonstrate the therapeutic potential of your product, you require fully compliant and high-quality bespoke vigilance and safety solutions that enable you to comply with the strictest regulatory requirements, manage the benefit-risk profile of your product and ensure patient safety.

compliance-rules-law-regulation-policy-business-technology-concept-xl_11040x6726px
smiling-professional-business-leaders-and-employees-group-team-portrait_7536-x-4630px

Dedicated Clinical Research Associates (CRAs)

Our in-house team of CRAs receives continuous training to ensure they remain knowledgeable and up to date with the latest techniques, technologies and regulatory developments. A Lead CRA dedicated to your study directs a team of field-based CRAs and oversees all monitoring activities carried out at participating investigational sites.

Risk-Based Monitoring Plan

We carefully design a risk-based monitoring plan, which serves as the framework for all monitoring activities. We focus on detecting, mitigating and preventing errors that may create risk, improving patient safety and enhancing the reliability of your clinical data. A patient-centric and proactive early-detection approach minimises risk and enables effective and efficient solutions.

diverse-business-people-negotiate-sit-at-conference-table-behind-closed-glass-door_8929-x-5953-px-1
businessman-hand-using-laptop-computer-with-mobile-phone-icon-on-screen_9360-x-6240-px

Remote Monitoring

When appropriate, we utilise virtual monitoring technology, allowing CRAs to perform monitoring activities remotely and reducing the significant costs and downtime associated with travel.

Stay Ahead of Vigilance Regulatory Requirements and Avoid Unnecessary Costs and Delays

Strict compliance with vigilance procedures and ICH Good Clinical Practice requirements helps minimise unnecessary costs and delays. Our team of vigilance specialists, comprising physicians, pharmacists and life sciences professionals, works closely with sponsors, investigators and regulatory authorities to effectively monitor, assess and report safety data in a timely and compliant manner.

Our capabilities include:

  • Vigilance consulting
  • EU QPPV and Local QPPV activities
  • Pharmacovigilance System Master File (PSMF)
  • Safety Data Exchange Agreements (SDEAs)
  • Risk Management Plans (RMPs) and Risk Evaluation and Mitigation Strategies (REMS)
  • SAE and SUSAR monitoring, reporting and follow-up 24/7
  • SOP development and support
  • Vigilance training
  • Safety database management (set-up, maintenance, etc.)
  • Preparation for audits and inspections
  • CAPA management
  • EudraVigilance
  • Benefit-risk assessment

Our laboratory

1, rue des Essarts, 38610 Gières, France

business-team-discussing-papers-at-office_8640-x-5760px

Supporting your clinical trials

Looking for a trusted partner to support your clinical trials? Let’s discuss how we can support your development programme.

Find a site near you!

Clear Filters
Reset Filters
Getting the map ready...